Abilify: The Perfect Antipsychotic?
The Carlat Psychiatry Report, Volume 1, Number 2, February 2003
https://www.thecarlatreport.com/newsletter-issue/tcprv1n2/
Issue Links: | Editorial Information
Daniel Carlat, MD
Dr. Carlat has disclosed that he has no significant relationships with or financial interests in any commercial companies pertaining to this educational activity.
Abilify (aripiprazole) is out! But you probably already know this, if your mailbox and fax machine have become as saturated with BMS-funded missives from CME, Inc. as mine have been. The hired guns are out in force once again, and so we front-line clinicians are faced with the task of separating the authentic wheat from the hyped-up chaff.
You can't view details of this content, please login or buy subscription here